Marfan Syndrome
Marfan Syndrome is a genetic disorder that affects the body's connective tissue, leading to features such as tall stature, long limbs, and an increased risk of cardiovascular problems like aortic aneurysms.
We are studying whether valsartan can slow down aortic root dilatation in children and young adults with Marfan syndrome. The trial will measure changes in aortic size and related health outcomes.
Health conditions and diseases that the clinical trial is designed to study and treat.
Marfan Syndrome is a genetic disorder that affects the body's connective tissue, leading to features such as tall stature, long limbs, and an increased risk of cardiovascular problems like aortic aneurysms.
Loeys-Dietz Syndrome is a genetic condition that affects connective tissue, leading to features similar to Marfan syndrome, including a risk of aortic aneurysms and other cardiovascular issues.
Ehlers-Danlos Syndrome is a group of disorders affecting connective tissues, characterized by hyper-flexible joints, skin that can be easily bruised, and a risk of cardiovascular complications.
Shprintzen-Goldberg Syndrome is a rare genetic disorder that affects connective tissue and can lead to craniofacial abnormalities and cardiovascular issues.
Arterial Tortuosity Syndrome is a rare connective tissue disorder characterized by tortuous arteries and a predisposition to vascular complications.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.